Atea Pharmaceuticals, Inc.(AVIR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AVIR Atea Pharmaceuticals, Inc.

交易中 04-16 09:50:46 EDT

5.82

-0.06

-1.02%

最高5.89	最低5.76	成交量5,856
今开5.88	昨收5.88	日振幅2.21%
总市值4.64亿	流通市值3.46亿	总股本7,967万
成交额3.43万	换手率0.01%	流通股本5,951万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AVIR","market":"US","secType":"STK","nameCN":"Atea Pharmaceuticals, Inc.","latestPrice":5.82,"timestamp":1776347400725,"preClose":5.88,"halted":0,"volume":5856,"delay":0,"changeRate":-0.010204081632652994,"floatShares":59509700,"shares":79672083,"eps":-1.943043,"marketStatus":"交易中","change":-0.06,"latestTime":"04-16 09:50:46 EDT","open":5.88,"high":5.89,"low":5.76,"amount":34309.033248,"amplitude":0.022109,"askPrice":5.85,"askSize":151,"bidPrice":5.81,"bidSize":101,"shortable":3,"etf":0,"ttmEps":-1.943043,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1776369600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1604030400000,"exchange":"NASDAQ","adjPreClose":5.88,"postHourTrading":{"tag":"盘后","latestPrice":5.88,"preClose":5.88,"latestTime":"16:10 EDT","volume":6043,"amount":35532.84,"timestamp":1776283808603,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.445216,"impliedVol":0.1583,"impliedVolPercentile":0.084},"requestUrl":"/m/hq/s/AVIR","defaultTab":"news","newsList":[{"id":"1166601867","title":"Atea Pharmaceuticals在Croi 2026公布临床前结果，支持首创药物AT-587治疗戊型肝炎病毒的潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=1166601867","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166601867?lang=zh_cn&edition=full","pubTime":"2026-02-24 20:05","pubTimestamp":1771934752,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals, Inc. (简称：Atea) 在近期举行的Croi 2026会议上，公布了其候选药物AT-587针对戊型肝炎病毒(HEV)的临床前研究数据。这些结果充分展示了AT-587作为同类首创疗法的巨大潜力。\n临床前研究数据显示，AT-587在体外和体内模型中均表现出强大的抗病毒活性，能有效抑制HEV的复制。该药物通过一种新颖的作用机制靶向病毒，为其作为潜在的一线治疗方案提供了有力支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AVIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608784702","title":"Atea Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608784702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608784702?lang=zh_cn&edition=full","pubTime":"2026-02-03 03:25","pubTimestamp":1770060316,"startTime":"0","endTime":"0","summary":"北京时间2026年02月03日03时25分，Atea Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.07%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203032516a6cb4b0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203032516a6cb4b0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135713656","title":"Atea制药公司将在第44届摩根大通医疗健康年会重点阐述2026年战略规划","url":"https://stock-news.laohu8.com/highlight/detail?id=1135713656","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135713656?lang=zh_cn&edition=full","pubTime":"2026-01-08 20:01","pubTimestamp":1767873678,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals, Inc. 宣布将于第44届摩根大通年度医疗健康大会期间，正式公布其面向2026年的核心战略重点。此次亮相将集中展示公司未来四年的发展蓝图与关键业务方向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVIR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601862027","title":"Atea Pharmaceuticals, Inc.盘中异动 快速下挫5.03%报3.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601862027","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601862027?lang=zh_cn&edition=full","pubTime":"2026-01-06 00:04","pubTimestamp":1767629058,"startTime":"0","endTime":"0","summary":"北京时间2026年01月06日00时04分，Atea Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.03%。截至发稿，该股报3.31美元/股，成交量6.6138万股，换手率0.08%，振幅3.16%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.70%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010600041997a10f20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010600041997a10f20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199754453","title":"Atea Pharmaceuticals完成北美第三阶段肝炎C病毒治疗试验的患者招募","url":"https://stock-news.laohu8.com/highlight/detail?id=1199754453","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199754453?lang=zh_cn&edition=full","pubTime":"2025-12-22 20:17","pubTimestamp":1766405830,"startTime":"0","endTime":"0","summary":"12月22日 - Atea Pharmaceuticals Inc ：*Atea Pharmaceuticals完成了北美第三阶段试验的患者招募，该试验评估了Bemnifosbuvir和Ruzasvir联合治疗肝炎C病毒的方案*。Atea Pharmaceuticals Inc - C-Beyond项目的初步结果预计于2026年中期公布*。Atea Pharmaceuticals Inc - C-Forward第三阶段试验的初步结果预计在2026年年底发布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AVIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190506114","title":"Atea Pharmaceuticals 完成北美第三阶段临床试验患者招募，评估 Bemnifosbuvir 和 Ruzasvir 联合治疗丙型肝炎病毒","url":"https://stock-news.laohu8.com/highlight/detail?id=1190506114","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190506114?lang=zh_cn&edition=full","pubTime":"2025-12-22 20:08","pubTimestamp":1766405298,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals 完成北美第三阶段临床试验患者招募，评估 Bemnifosbuvir 和 Ruzasvir 联合治疗丙型肝炎病毒。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AVIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518281053","title":"Atea Pharmaceuticals, Inc.2024财年实现净利润-1.68亿美元，同比减少23.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518281053","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518281053?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536076,"startTime":"0","endTime":"0","summary":"3月10日，Atea Pharmaceuticals, Inc.公布财报，公告显示公司2024财年净利润为-1.68亿美元，同比减少23.53%；其中营业收入为0.00美元，每股基本收益为-2.00美元。机构评级：截至2025年3月10日，当前有1家机构对Atea Pharmaceuticals, Inc.目标价做出预测，其中目标均价为6.20美元，其中最低目标价为6.20美元，最高目标价为6.20美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000238a268987a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000238a268987a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144965686","title":"Atea Pharmaceuticals公司第四季度每股亏损0.40美元，未达到预期的每股亏损0.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1144965686","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144965686?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:19","pubTimestamp":1741295973,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals  公布的季度每股亏损为0.40美元，未达到分析师普遍预计的每股亏损0.37美元，差8.11%。相比去年同期的每股亏损0.47美元，这一亏损减少了14.89%。以上内容来自Benzinga Earnings专栏，原文如下：Atea Pharmaceuticals  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 8.11 percent. This is a 14.89 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Atea Pharmaceuticals公司第四季度每股亏损0.40美元，未达到预期的每股亏损0.37美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509253138","title":"Atea Pharmaceuticals, Inc.盘中异动 股价大涨5.05%报3.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509253138","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509253138?lang=zh_cn&edition=full","pubTime":"2025-02-06 03:31","pubTimestamp":1738783883,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日03时31分，Atea Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.05%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为2.41%。其相关个股中，Invivyd, Inc.、Transcode Therapeutics, Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4636.38%、2352.41%、1754.62%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Invivyd, Inc.，振幅分别为132.24%、99.51%、69.59%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206033124a23ab96d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206033124a23ab96d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500149497","title":"Atea Pharmaceuticals, Inc.盘中异动 大幅拉升5.12%报3.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500149497","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500149497?lang=zh_cn&edition=full","pubTime":"2025-01-04 01:03","pubTimestamp":1735923780,"startTime":"0","endTime":"0","summary":"北京时间2025年01月04日01时03分，Atea Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.12%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104010300985a55bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104010300985a55bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500971389","title":"Atea Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500971389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500971389?lang=zh_cn&edition=full","pubTime":"2025-01-03 00:14","pubTimestamp":1735834476,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日00时14分，Atea Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.37%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103001436985912f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103001436985912f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493426281","title":"Atea Pharmaceuticals, Inc.盘中异动 股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493426281","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493426281?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:50","pubTimestamp":1734713422,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时50分，Atea Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.11%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221005022984cfe97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221005022984cfe97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491692122","title":"Atea Pharmaceuticals, Inc.盘中异动 股价大涨9.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491692122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491692122?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:31","pubTimestamp":1734359486,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时31分，Atea Pharmaceuticals, Inc.股票出现异动，股价急速上涨9.22%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223126a1f3428c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223126a1f3428c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490042519","title":"Atea Pharmaceuticals, Inc.盘中异动 股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490042519","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490042519?lang=zh_cn&edition=full","pubTime":"2024-12-11 02:25","pubTimestamp":1733855133,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日02时25分，Atea Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.30%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.92%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211022533a1e3fb75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211022533a1e3fb75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2489468852","title":"Atea Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.14%报2.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489468852","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489468852?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:38","pubTimestamp":1733409511,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时38分，Atea Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.14%。截至发稿，该股报2.96美元/股，成交量2.6289万股，换手率0.03%，振幅4.82%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223831a1d69d5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223831a1d69d5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2488190863","title":"Atea Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.17%报3.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488190863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488190863?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:57","pubTimestamp":1733324277,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日22时57分，Atea Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.17%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204225757971ba1f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204225757971ba1f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2484548975","title":"Atea Pharmaceuticals, Inc.2024财年第三财季实现净利润-31.15百万美元，同比增加6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484548975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484548975?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:04","pubTimestamp":1731773092,"startTime":"0","endTime":"0","summary":"11月17日，Atea Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第三财季净利润为-31.15百万美元，同比增加6.00%；其中营业收入为0.00美元，每股基本收益为-0.37美元。机构评级：截至2024年11月17日，当前有1家机构对Atea Pharmaceuticals, Inc.目标价做出预测，其中目标均价为6.20美元，其中最低目标价为6.20美元，最高目标价为6.20美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000621a23e0832&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000621a23e0832&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2481984476","title":"Atea Pharmaceuticals, Inc.盘中异动 急速拉升5.06%报3.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481984476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481984476?lang=zh_cn&edition=full","pubTime":"2024-11-06 23:21","pubTimestamp":1730906482,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日23时21分，Atea Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.06%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110623212298e40ed4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110623212298e40ed4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2477189166","title":"Atea Pharmaceuticals, Inc.盘中异动 大幅跳水5.10%报3.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477189166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477189166?lang=zh_cn&edition=full","pubTime":"2024-10-22 01:34","pubTimestamp":1729532048,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日01时34分，Atea Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.10%。截至发稿，该股报3.63美元/股，成交量8.7629万股，换手率0.10%，振幅6.02%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.76%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022013408971a16c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022013408971a16c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2475171389","title":"Atea Pharmaceuticals, Inc.盘中异动 大幅上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475171389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475171389?lang=zh_cn&edition=full","pubTime":"2024-10-16 23:30","pubTimestamp":1729092655,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日23时30分，Atea Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.01%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016233056971a0a9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016233056971a0a9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ateapharma.com","stockEarnings":[{"period":"1week","weight":-0.0084},{"period":"1month","weight":-0.0281},{"period":"3month","weight":0.7093},{"period":"6month","weight":0.9216},{"period":"1year","weight":1.0851},{"period":"ytd","weight":0.6471}],"compareEarnings":[{"period":"1week","weight":0.0354},{"period":"1month","weight":0.0462},{"period":"3month","weight":0.0111},{"period":"6month","weight":0.0535},{"period":"1year","weight":0.3019},{"period":"ytd","weight":0.0264}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Atea Pharmaceuticals, Inc.于2012年7月注册成立，并于2014年3月开始主要运营。该公司是一家临床阶段的生物制药公司，利用对抗病毒药物开发、药物化学、生物学、生物化学和病毒学的深刻理解，发现和开发新型口服候选产品，以治疗严重的病毒性疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.162254},{"month":2,"riseRate":0.5,"avgChangeRate":-0.030852},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.003624},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.135883},{"month":5,"riseRate":0.6,"avgChangeRate":0.077532},{"month":6,"riseRate":0.4,"avgChangeRate":0.000859},{"month":7,"riseRate":0.8,"avgChangeRate":0.080594},{"month":8,"riseRate":0.4,"avgChangeRate":0.002411},{"month":9,"riseRate":0.2,"avgChangeRate":-0.087115},{"month":10,"riseRate":0.6,"avgChangeRate":-0.088466},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.082616},{"month":12,"riseRate":0.833333,"avgChangeRate":0.089295}],"exchange":"NASDAQ","name":"Atea Pharmaceuticals, Inc.","nameEN":"Atea Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Atea Pharmaceuticals, Inc.(AVIR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Atea Pharmaceuticals, Inc.(AVIR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Atea Pharmaceuticals, Inc.,AVIR,Atea Pharmaceuticals, Inc.股票,Atea Pharmaceuticals, Inc.股票老虎,Atea Pharmaceuticals, Inc.股票老虎国际,Atea Pharmaceuticals, Inc.行情,Atea Pharmaceuticals, Inc.股票行情,Atea Pharmaceuticals, Inc.股价,Atea Pharmaceuticals, Inc.股市,Atea Pharmaceuticals, Inc.股票价格,Atea Pharmaceuticals, Inc.股票交易,Atea Pharmaceuticals, Inc.股票购买,Atea Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Atea Pharmaceuticals, Inc.(AVIR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Atea Pharmaceuticals, Inc.(AVIR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}